About A N Pharmaceuticals Private Limited
Data last updated:
A N Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 November 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2000PTC108617. Its GSTIN is 07AADCA5123E1Z7 (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹98.5 Lakh. It is led by directors Anil Arora (Managing Director) and Rishabh Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 1/4 Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.77 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.55 Cr (net margin 4.3%) and EBITDA of ₹3.08 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over five years.
The company is associated with 1 brand: An Pharma. As per MCA filings, the company has open charges of ₹18.62 Cr and satisfied charges of ₹5.15 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it. The company has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.65 Cr; the latest was in February 2019. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Jayhida Medicare Private Limited with revenue of ₹35.94 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2021, listing 12 overdue payments to 3 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressF – 1/4 Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of A N Pharmaceuticals Private Limited
The main business activity of A N Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of A N Pharmaceuticals Private Limited FY 2025 filings available
A N Pharmaceuticals Private Limited reported revenue of ₹35.77 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of A N Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 2% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of A N Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.08 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.55 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of A N Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of A N Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of A N Pharmaceuticals Private Limited
A N Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jayhida Medicare Private Limited | ₹35.94 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Hyderabad, Telangana, India |
| Salas Pharmaceuticals Private Limited | ₹35.84 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Patna, Bihar, India |
| Unimed Investments Limited | ₹35.8 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Vadodara, Gujarat, India |
| Radicura Pharmaceuticals Private Limited | ₹35.79 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Vetindia Pharmaceuticals Limited | ₹35.78 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Telangana, India |
| A N Pharmaceuticals Private Limited this company | ₹35.77 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Salem Institute of Medical Sciences and Hospitals Private Limited | ₹35.74 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Salem, Tamil Nadu, India |
| Aashish Bio Business Private Limited | ₹35.61 Cr (FY 2025) | •••• | •••• | 109.0% | •••• | Telangana, India |
| Mukesh Pharma Private Limited | ₹35.54 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Noida, Uttar Pradesh, India |
| Rasayan Marketing Private Limited | ₹35.54 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Schon Pharmaceuticals Limited | ₹35.42 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below A N Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of A N Pharmaceuticals Private Limited
A N Pharmaceuticals Private Limited is audited by H. L. BANSAL & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H. L. BANSAL & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of A N Pharmaceuticals Private Limited
A N Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Arora Also directs: Aurora Nutraceuticals Private Limited | Managing Director | 22 Nov 2000 | 25 Years 10 Months | Current |
| Rishabh Arora Also directs: Aurora Nutraceuticals Private Limited, Abhishek Synfab Private Limited, Anjani Metals Private Limited and 1 more | Director | 03 Jan 2023 | 3 Years 9 Months | Current |
Ownership and Shareholding of A N Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of A N Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Dec 2024 | Hdfc Bank Limited | ₹8.45 Cr | Open |
| 03 May 2021 | Hdfc Bank Limited | ₹66.61 Lakh | Open |
| 04 Jan 2021 | Hdfc Bank Limited | ₹9.5 Cr | Open |
| 09 Feb 2011 | Ing Vysya Bank Limited | ₹3 Cr | Satisfied |
| 26 Apr 2006 | Canara Bank | ₹15 Lakh | Satisfied |
Total charge records: 7 View all charges
Deals & Funding of A N Pharmaceuticals Private Limited
A N Pharmaceuticals Private Limited has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.65 Cr; the latest was in February 2019.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹2.34 Cr | Investors: Soorajmull Baijnath Industries Pvt Ltd , 3 individuals |
| Dec 2018 | Rights issue | ₹49.3 Lakh | Investors: 2 individuals |
| Apr 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Anil Arora HUF, 2 individuals Seller: 4 individuals |
Full deal history
All 9 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of A N Pharmaceuticals Private Limited
A N Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by A N Pharmaceuticals, 2 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed by the company against Agusto Formulations Private Limited | Disposed |
| District court, South, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, Central, Delhi | Court case (LCA) | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by A N Pharmaceuticals Private Limited
A N Pharmaceuticals Private Limited has 6 MSME Form 1 returns on record between 2019 and 2021, listing 12 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Symbiosis Pharmaceuticals Private Limited | •••• | •••• | •••• |
| Apco Pharma Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 6 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with A N Pharmaceuticals Private Limited
A N Pharmaceuticals operates one associated brand: An Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical marketing company with a network in Delhi-NCR and UP. | anpharmaceuticals.com |
Employees and EPFO Compliance at A N Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to A N Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on A N Pharmaceuticals Private Limited
A N Pharmaceuticals Private Limited has 8 board changes on record since 2000: 2 appointments and 6 cessations. The latest: Rishabh Arora ceased to be Additional Director on 26 Sep 2023.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for A N Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of A N Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of A N Pharmaceuticals Private Limited
A N Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCA5123E1Z7 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of A N Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about A N Pharmaceuticals Private Limited
A N Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 November 2000 (26+ years old) and is registered under CIN U24233DL2000PTC108617.
A N Pharmaceuticals reported revenue of ₹35.77 Cr for FY 2025 (up 2% YoY).
A N Pharmaceuticals has 2 current directors:
- Anil Arora - Managing Director
- Rishabh Arora - Director
A N Pharmaceuticals reported a net profit of ₹1.55 Cr (net margin 4.3%) and EBITDA of ₹3.08 Cr (EBITDA margin 8.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of A N Pharmaceuticals is 5% over five years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of A N Pharmaceuticals is 07AADCA5123E1Z7, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of A N Pharmaceuticals is U24233DL2000PTC108617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
A N Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it.
A N Pharmaceuticals was incorporated on 22 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
A N Pharmaceuticals has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.65 Cr; the latest was in February 2019.
The peers of A N Pharmaceuticals by revenue are Jayhida Medicare Private Limited, Salas Pharmaceuticals Private Limited, Unimed Investments Limited, Radicura Pharmaceuticals Private Limited, Vetindia Pharmaceuticals Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Rishabh Arora ceased to be Additional Director on 26 Sep 2023. Rishabh Arora was appointed as Director on 03 Jan 2023. Amit Jha ceased to be Additional Director on 30 Sep 2019. A N Pharmaceuticals has 8 board changes on record in total.